Optimization of combined antitumor chemotherapy with bevacizumab by means of mathematical modeling

DOI10.1007/978-3-319-91092-5_24MaRDI QIDQ4556944zbMATH OpenOpenAlexFDO

Authors M. B. Kuznetsov, A. V. Kolobov

Publication date 28 November 2018

Published in Trends in Biomathematics: Modeling, Optimization and Computational Problems (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1007/978-3-319-91092-5_24

zbMATH Keywords

bevacizumabantitumor chemotherapypalliative combined chemotherapy

Mathematics Subject Classification ID

Medical applications (general) (92C50) PDEs in connection with biology, chemistry and other natural sciences (35Q92)

Recommendations

• Mathematical modelling of chemotherapy combined with bevacizumab
• The study of antitumor efficacy of bevacizumab antiangiogenic therapy using a mathematical model
• Mathematical modeling in scheduling cancer treatment with combination of VEGF inhibitor and chemotherapy drugs
• A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology
• Optimizing the delivery of combination therapy for tumors: A mathematical model

Cites work

• Flux-corrected transport. I: SHASTA, a fluid transport algorithm that works
• Preface
• The Role of Cell Motility in Metastatic Cell Dominance Phenomenon: Analysis by a Mathematical Model
• The study of antitumor efficacy of bevacizumab antiangiogenic therapy using a mathematical model

Cited in

(7)

• Optimizing the delivery of combination therapy for tumors: A mathematical model
• Mathematical modelling of chemotherapy combined with bevacizumab
• Analysis of anticancer efficiency of combined fractionated radiotherapy and antiangiogenic therapy via mathematical modelling
• The study of antitumor efficacy of bevacizumab antiangiogenic therapy using a mathematical model
• Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice
• A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology
• Mathematical modeling in scheduling cancer treatment with combination of VEGF inhibitor and chemotherapy drugs

This page was built for publication: Optimization of combined antitumor chemotherapy with bevacizumab by means of mathematical modeling

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4556944)